FDA Approves Preservative-Free Xelpros™ for Open-Angle Glaucoma
FDA Approves preservative-free XELPROS™ (latanoprost ophthalmic emulsion 0.005%) for intraocular pressure (IOP) reduction in patients with open-angle glaucoma and ocular hypertension
Vesneo: A New Glaucoma Medication With Dual Action
Vesneo (latanoprostene bunod) is an experimental glaucoma medication developed by French pharmaceutical firm Nicox. It is essentially a prostaglandin analog “plus”. Find out more…
Could a New Class of Glaucoma Medications Be Around The Corner?
An exciting new class of potential glaucoma medications include what are termed the ROCK and ROCK/NET inhibitors. And it’s about time! Twenty years have passed since the last new class of medications (prostaglandin analogs) were approved for the treatment of glaucoma.
